XBIT — XBiotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for XBiotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	715	237	237	217	200
Net Total Accounts Receivable
Net Total Receivables	—	85.8	8.95	1.76	0.935
Prepaid Expenses
Total Other Current Assets
Total Current Assets	716	326	247	220	202
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25.2	27.3	28.3	26.3	24.9
Long Term Notes Receivable
Other Long Term Assets
Total Assets	817	354	275	246	227
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	60.2	3.98	3.45	4.07	6.1
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	61.2	5.11	5.79	5.7	7.77
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	756	349	269	240	219
Total Liabilities & Shareholders' Equity	817	354	275	246	227
Total Common Shares Outstanding